Clinical trial
A 'Proof of Concept' Study to Identify Neural Target Engagement of Escitalopram in Adolescents With Autism Spectrum Disorder
NCT06826326 is registered in ClinicalTrials.gov with Kathryn Unruh as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A 'Proof of Concept' Study to Identify Neural Target Engagement of Escitalopram in Adolescents With Autism Spectrum Disorder
- Lead sponsor
- Kathryn Unruh
- Phase
- Phase 2
- Overall status
- Enrolling by invitation
- Start date
- April 28, 2025
- Completion date
- December 30, 2026
- Enrollment
- 5 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.